0001004724false00010047242026-11-102026-11-10

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 10, 2026

Regional Health Properties, Inc.

(Exact Name of Registrant as Specified in its Charter)

Georgia

001-33135

81-5166048

(State or Other Jurisdiction

(Commission

(I.R.S. Employer

of Incorporation)

File Number)

Identification No.)

1050 Crown Pointe Parkway

Suite 720

Atlanta, Georgia 30338

(Address of Principal Executive Offices, and Zip Code)

(678) 869-5116

(Registrant’s telephone number, including area code)

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.07. Submission of Matters to a Vote of Security Holders.

On November 10, 2026, the Company held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”) at Suite 150, 1050 Crown Pointe Parkway, Atlanta, Georgia 30338 at 10:00 a.m. Following is a summary of the proposals that were submitted to the holders of the Company’s common stock, no par value per share (the “common stock”), the 12.5% Series B Cumulative Redeemable Preferred Shares, no par value per share (the “Series B Preferred Stock”), and the Series D 8.0% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share ("the Series D Preferred Stock") for approval at the Annual Meeting and a tabulation of the votes with respect to each proposal. Each proposal is further described in the Proxy Statement.

Proposal 1(a). To elect the three director nominees named in the Proxy Statement.

The common stock shareholders elected the following three individuals to the Company’s board of directors (the “Board”) to serve until the Company’s 2027 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal. The voting results were as follows:

Nominee

 

For

 

Withheld

 

Broker Non-Votes

Brent Morrison

 

1,318,300

 

149,438

 

1,567,721

Kenneth W. Taylor

 

994,417

 

473,321

 

1,567,721

F. Scott Kellman

 

1,019,373

 

448,365

 

1,567,721

 

 

 

 

 

 

 

 

Proposal 1(b). To elect one director nominee named in the Proxy Statement.

The Series B Preferred Stock shareholders elected the following individual to the Board to serve until the Company’s 2027 Annual Meeting of Shareholders and until his successor is elected and qualified, or until his earlier death, resignation or removal. The voting results were as follows:

Nominee

 

For

 

 

Withhold

Steven L. Martin

 

787,498

 

 

275,900

 

 

Proposal 1(c). To elect the two directors nominees named in the Proxy Statement.

The Series D Preferred Stock shareholders elected the following individuals to the Board to serve until the Company’s 2027 Annual Meeting of Shareholders and until their respective successors are elected and qualified, or until their earlier death, resignation or removal. The voting results were as follows:

Nominee

 

For

 

 

Withhold

Steven J. Baileys

 

357,478

 

 

444,847

Gene E. Burleson

 

357,478

 

 

444,847

 

 

Proposal 2. To ratify the appointment of Cherry Bekaert, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

The common stock shareholders ratified the appointment of Cherry Bekaert, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows:

For

 

Against

 

Abstain

2,903,966

 

83,171

 

48,322

* * *


 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

REGIONAL HEALTH PROPERTIES, INC.

Date:

November 12, 2026

By:

/s/ Brent Morrison

Brent Morrison

Chief Executive Officer and President